Immune checkpoint therapy for ER+ breast cancers, a missed opportunity?
(Baylor College of Medicine) A subset of endocrine therapy-resistant luminal B breast cancers activates immune responses that could be amenable to manipulation with immunotherapy.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Baylor College of Medicine | Cancer | Cancer & Oncology | Endocrine Therapy | Immunotherapy